[Clinical evaluation of amitryptyline hydrochloride in the treatment of depression].
Thirty subjects between 18 and 66 years of age with overt symptoms of depression were followed during treatment with amytryptiline. Daily dose was 75 mg in three parts for a period of three months. Thirteen subjects showed total remission from the tenth week; 15 showed significant improvement from the third week; 2 showed no change. Side effects were mild and required no medical intervention.